海外の高周波焼灼術のベスト医師 — ページ3

フィリズジャン医師は、デジタル歯科およびインプラント学に重点を置いた補綴歯科治療を専門としています。

• ハジェテペ大学にて補綴歯科の博士号（Ph.D.）を取得
• 欧州オッセオインテグレーション学会会員
• インプラント支持冠および修復材料に関する研究論文を発表

エルドアン医師は、世界トップクラスの心臓病センターであるメイヨークリニックの心エコー検査ラボで研修を受けました。彼はその専門知識をメディカルパーク・アンタルヤ病院コンプレックスにもたらしています。

• _doctor_9564_年_の循環器科での経験
• インターベンション循環器治療を専門とする
• 学術的資格を持つ准教授
• 高度な心臓アブレーション技術を実施

ファティ・コチ医師は、米国トップクラスの心臓センターであるクリーブランド・クリニックの侵襲的循環器科ユニットで研修を受けました。

• セルチュク大学で循環器科を専門に研修
• アクデニズ大学循環器科に勤務
• メディカル・パーク・アンタルヤ病院コンプレックスにて診療

リザ・トゥルコズ教授は高周波アブレーションを専門とし、トルコのトップ病院のインターベンション放射線科で_doctor_9567_年以上の経験を有しています。

• Acıbadem Bakırköy病院で教授職を務める
• エーゲ大学およびイズミル・アタテュルク教育研究病院で研修
• 以前はバシュケント大学で准教授を務めた

Dr. Gokhan Bektasoglu is a cardiologist trained at the Faculties of Medicine of Hacettepe University and Cumhuriyet University. He has worked at Medicine Hospital (2014). He also served at Private European Dawn Hospital, Atrium Cardiology Center (2012–2014); Izmir Karşıyaka State Hospital (2011–2012); Okmeydanı Training and Research Hospital (2011); and Uzunköprü State Hospital (2009–2011).

His clinical focus includes coronary and peripheral angiography with balloon and stent procedures. He performs carotid stenting, EVAR, and TEVAR. He is experienced in echocardiography and TEE. He manages device therapy (pacemaker, ICD, CRT) and arrhythmias. He treats heart failure. He performs ASD and VSD closure. He also offers valve therapies, including TAVI, mitral balloon valvuloplasty, and MitraClip. He has published in the American Journal of Cardiology, American Journal of Emergency Medicine, Journal of Thrombosis and Thrombolysis, European Journal of Echocardiography, Bratislava Medical Journal, and International Journal of Angiology. He has presented at international cardiology meetings.

ミン・ジョン・キム医師は仁川セジョン病院のインターベンション心臓病学を専門とし、冠動脈疾患および不整脈の治療に精通しています。

• 冠動脈造影および経皮的冠動脈インターベンションに熟練
• エビデンスに基づいたケアと個別化された治療計画に注力
• ソウル大学校医学部で研修
• 予防心臓病学と長期的な心疾患管理を重視

ヤイール・バー博士は、シェバ医療センターの癌センターの副所長であり、胸部腫瘍内科医です。進行非小細胞肺癌の治療において、個別化免疫療法および標的療法を専門としています。分子生物学の博士号（PhD）を取得しており、免疫療法耐性に焦点を当てた研究室を主導しています。

• イスラエル肺癌グループの議長。
• 腫瘍内科および放射線腫瘍学の専門医認定を取得。
• 世界トップ10にランクされるシェバ医療センターで患者を治療。
• 分子・遺伝子プロファイリングを用いて、精密な癌治療計画を作成。

ラーナン・バーガー博士は、シェバ医療センターがんセンターのセンター長です。2025年にはForbesイスラエルの「ベストドクター」リストに選出されました。バーガー博士は泌尿器腫瘍学を専門とし、複雑な前立腺腫瘍への放射線治療を行っています。ダナ・ファーバー/ハーバードがん研究所で博士研究員としてのフェローシップを修了しました。

• 分子腫瘍学に焦点を当てた臨床研究ユニットを統括。
• 前立腺がんとBRCA変異に関する20本以上の査読付き論文の共著者。
• 米国臨床腫瘍学会（ASCO）会員。
• 世界トップ10にランクされる病院で全身療法および放射線療法を実施。

イルハン・マヴィオグル医師は、オプティメド国際病院の心臓血管外科医です。心臓血管外科外来クリニックを統括しています。低侵襲の無大動脈冠動脈バイパス術や、覚醒下での頸動脈手術を行います。マヴィオグル医師はデュズジェ大学の教授であり、グレート・オーモンド・ストリート病院で研修を受けました。完全動脈血行再建術および複雑な血管内治療を専門としています。

• ロボット支援下僧帽弁形成術および血管内手術技術の認定を受けています。
• 末梢血管疾患に対するEVAR、FEVAR、CERAB手術を行います。
• 欧州心臓血管外科学会会員。
• J Card Surgなどのジャーナルに400本以上の科学論文を発表しています。

Byung-Hee Oh教授は心不全と不整脈を専門とし、心血管医学において数十年にわたるリーダーシップを発揮しています。

• インターベンション心臓病学における30年以上の経験
• 元韓国心臓学会会長
• 数百件の査読付き心臓病学論文の著者
• ソウル大学校卒業および研修修了

ムラット・スンブル教授は、イスティニエ大学リブ病院トプカプにて、複雑な冠動脈インターベンションおよび高度な心臓画像診断を専門としています。

• 循環器内科における_doctor_10983_年以上の経験
• FFR、OCT、IVUSなどの冠動脈画像診断技術の専門家
• 循環器内科に関する100本以上の科学論文を発表
• マルマラ大学医学部循環器内科教授

キム・ドゥク・ギョン医師は、サムスン医療センターで高周波アブレーション手術を専門としています。

• アブレーション技術に精通した循環器専門医
• 韓国有数の医療機関であるサムスン医療センターに勤務
• 不整脈の治療選択肢の向上に尽力

カブレラ医師はオリンピア・キロンサルードの循環器科を率いており、1994年以来、高周波アブレーションに重点を置いた不整脈治療を専門としています。

• ヌエストラ・セニョーラ・デル・ピノ大学病院の不整脈ユニットを設立・指揮
• フンダシオン・ヒメネス・ディアス電気生理学研究所の元所長
• 自治大学の循環器学教授
• 2022年よりオリンピアセンター循環器科の現責任者

ヤーコフ・ローレンス医師は、シェバ医療センターの放射線腫瘍科部長です。精密放射線治療と神経腫瘍学を専門としています。ローレンス医師は、膵臓がんの疼痛管理のための腹腔神経叢ラジオサージェリー（放射線外科）の先駆者です。専門分野における最高の名誉の一つであるFASTROの称号を保持しています。

• シェバ医療センターの消化器がんプログラムを主導。
• 脳腫瘍および神経系がんに対する定位放射線外科手術を実施。
• 個別化された放射線プロトコルに関する280以上の科学論文を執筆。
• トーマス・ジェファーソン大学で放射線腫瘍学のフェローシップ研修を修了。

高周波アブレーションを含む心血管外科を専門とし、エーゲ大学医学部で研修を受けた。

• トルコ心血管外科学会会員
• 体外循環および虚血性脳損傷に関する研究を発表
• 大動脈、心臓弁、冠動脈手術の経験豊富

モニ・シュヴィ医師は、ハダッサ医療センターにて、心臓弁膜症に重点を置いたインターベンション心臓病学を専門としています。

• 僧帽弁手術における専門知識
• PCIおよび冠動脈造影の技術
• 心筋梗塞治療の専門

Zhang Jinshan, male, China’s First M.D. in the Radiation Medicine, CCI (Chinese College of Interventionalists) Master Interventionalist, Director of the Department of Former Radiological Diagnosis at Chinese PLA General Hospital(No.3 in China) Ph.D. of Medicine, Nagasaki University, Japan.

1980–1985: Completed doctoral studies at Nagasaki University, Japan

1968–present: Department of Radiology, Chinese PLA General Hospital

1988: Third Prize of the Military Science and Technology Progress Award

1989–present: Member of Radiological Society of North America(RSNA)

1990–2009: Standing Committee Member of the Radiology and Therapeutic Radiology Committee of the PLA

1991: Second Prize of the Military Science and Technology Progress Award

1992–2008: Group Leader of the Group of Intervention of Chinese Journal of Radiology

1992–2015: Standing Editorial Board Member and Editorial Board Member of Journal of Interventional Radiology

1993: Granted the Lifetime Special Government Allowance of the State Council

1993–2012: Deputy Chief Editor of Chinese Journal of Medical Image Technology

1994: Third Prize of the Military Science and Technology Progress Award

1997: Second Prize of the Military Science and Technology Progress Award

1997–2009: Standing Member of Chinese Society of Radiology

1999: Third Prize of the Military Science and Technology Progress Award

1999–2010: Deputy Director Member of Chinese Society of Interventional Oncology

2002: Second Prize of the Military Science and Technology Progress Award

2005: Third Prize of the Military Science and Technology Progress Award

Member of Radiological Society of North America(RSNA)

Standing Member of Chinese Society of Radiology

Group Leader of the Group of Intervention of Chinese Journal of Radiology

Deputy Director Member of Chinese Society of Interventional Oncology

Director Member of Beijing Medical Association Society of Interventional Radiology

Deputy Chief Editor of Chinese Journal of Medical Image Technology

Standing Member of Professional Committee of Radiological Medicine of the Chinese People’s Liberation Army

Standing Editorial Board Member and Editorial Board Member of Journal of Interventional Radiology

Awarded the Special Government Allowance of the State Council

Awarded three Second Prizes and four Third Prizes for Military Science and Technology Progress.

Awarded the honorary title of “Chinese College of Interventionalists(CCI) Master Interventionalist”

Led multiple national and provincial/ministerial scientific research projects, including two projects funded by the National Natural Science Foundation of China and two projects funded by the Department of Science and Technology of Sichuan Province.

In the pioneering development of interventional medicine in China, Zhang Jinshan has been an indispensable founder and leading figure. As China’s first overseas-trained doctoral graduate in radiological medicine, he returned to China in the 1980s after completing his studies abroad and introduced cutting-edge international interventional technologies to the country. Over more than four decades of dedicated practice and research, he has helped propel Chinese interventional medicine from its infancy to a position at the forefront of the global field through his exceptional clinical expertise and profound academic accomplishments.

Professor Zhang Jinshan has long been dedicated to the field of medical imaging and has developed distinctive expertise in selective and superselective interventional diagnosis and treatment for solid tumors such as liver cancer, demonstrating exceptional technical proficiency and profound academic accomplishment. Beginning in the 1990s, he led his team in pioneering the clinical application and research of TIPSS and B-ORTO in China, filling major gaps in the domestic field and opening new paths for the interventional management of gastrointestinal bleeding caused by portal hypertension secondary to liver cirrhosis. In addition, he has made groundbreaking contributions to the interventional diagnosis and treatment of peripheral vascular diseases, as well as to preoperative embolization for spinal tumors.

In the field of liver cancer treatment, Professor Zhang Jinshan not only led the development of standardized treatment protocols for liver cancer but also pioneered Transcatheter Arterial Chemoembolization with temporary Hepatic Vein Thrombosis (TACE-THVO) for primary liver cancer, bringing the efficacy of interventional therapy to a new level. In recognition of his outstanding clinical and scientific contributions, he was awarded the honorary title of “Chinese Master of Interventional Radiology” at the 2019 annual conference of the Chinese College of Interventionalists.

Professor Zhang Jinshan is not only a master clinician but also a driving force in the development of the discipline and a dedicated mentor in talent cultivation. He led his team in establishing one of China’s premier interventional therapy centers. As a doctoral supervisor, he has trained a large number of outstanding specialists and future leaders in interventional medicine, with many of his students and protégés now serving across the country. Academically, he has led multiple key national and military research projects, published more than 300 academic papers, and served as chief editor of three monographs, making remarkable contributions to the establishment of China’s academic framework for interventional medicine and the nationwide dissemination of its technologies.

From the laboratory to the operating room, and from academic podiums to grassroots hospitals, Professor Zhang Jinshan has consistently upheld the principles of “pioneering, innovation, pragmatism, and compassion". He has devoted his life to fulfilling the mission of a physician—relieving patients’ suffering through minimally invasive techniques and advancing the discipline through academic excellence—thereby establishing himself as a truly towering figure and one of the foremost authorities in the field of interventional medicine in China.

Professor Zhang Jinshan’s Academic Achievements

Professor Zhang Jinshan has achieved prolific academic accomplishments, having published over 300 academic papers covering areas such as interventional therapy for liver cancer, minimally invasive treatment of portal hypertension, interventional treatment of vascular diseases, and tumor ablation.

Selected Publications by Professor Zhang Jinshan

1. Zhang Jinshan, Wang Maoqiang. Experiments and Clinical Studies of transjugular intrahepatic portosystemic stent shunt (TIPSS). Chinese Journal of Radiology, 1993，27（6）：361-365.

Professor Zhang Jinshan is the first author. This is one of the early research papers in China that systematically elaborates on the TIPSS technique. Through animal experiments and clinical case analysis, it confirmed that TIPSS is a safe and effective minimally invasive method for treating portal hypertension and its complications, laying an important foundation for the promotion and application of this technique in China.

2.Zhang Jinshan, Li Huai. Clinical study on transcatheter arterial embolization with temporary hepatic vein occlusion for the treatment of primary liver cancer.Chinese Journal of Radiology, 1996，30（8）：521-524.

Professor Zhang Jinshan is the first author. He innovatively proposed the technique of "transcatheter arterial embolization with temporary hepatic vein occlusion." Clinical results demonstrated that this method can significantly increase the drug concentration within liver cancer lesions, reduce damage to normal liver tissue, and effectively improve the therapeutic outcomes for intermediate and advanced liver cancer, providing a novel strategy for the interventional treatment of liver cancer.

3. Zhang Jinshan, Wang Maoqiang, Li Huai. Interventional treatment of Budd-Chiari syndrome. Chinese Journal of Medical Imaging Technology, 1998，14（3）：189-191.

Professor Zhang Jinshan is the first author. This paper systematically summarizes the early experience in interventional treatment of Budd-Chiari syndrome in China, elaborating in detail on the key operational points and therapeutic efficacy of techniques such as percutaneous transluminal angioplasty and stent placement. It confirms that interventional therapy is the preferred minimally invasive method for Budd-Chiari syndrome, promoting the standardized development of treatment for this disease.

4.Zhang Jinshan, Li Huai, Wang Maoqiang. Clinical value of superselective hepatic arterial chemoembolization in the treatment of hypovascular liver cancer. Chinese Journal of Radiology, 2000，34（5）：335-337.

Professor Zhang Jinshan is the first author. Addressing the challenges in interventional treatment of hypovascular liver cancer, this paper explores the clinical efficacy of superselective hepatic arterial chemoembolization. The results indicate that this technique can precisely target the lesions and improve the treatment response rate, providing an important clinical basis for the interventional treatment of hypovascular liver cancer.

5. Zhang Jinshan, Li Huai, Wang Maoqiang. Interventional treatment of peripheral vascular stenosis and occlusion.Chinese Journal of Radiology, 2002，36（7）：612-614.

Professor Zhang Jinshan is the first author. This paper summarizes the interventional treatment experience of over 400 patients with peripheral vascular stenosis and occlusion, analyzing the indications and efficacy of techniques such as balloon angioplasty and stent placement. It confirms that interventional therapy is a safe and effective approach for peripheral vascular diseases, providing practical support for its clinical promotion.

6.Zhang Jinshan, Li Huai, Wang Maoqiang. Clinical application of CT-guided percutaneous puncture ablation in the treatment of abdominal tumors. Chinese Journal of Medical Imaging Technology, 2004，20（9）：1395-1397.

Professor Zhang Jinshan is the first author. This paper explores the application value of CT-guided percutaneous puncture techniques such as radiofrequency ablation and chemical ablation in the treatment of abdominal tumors. The clinical results show that this method is minimally invasive with reliable efficacy, offering a minimally invasive treatment option for patients with inoperable abdominal tumors.

7.Zhang Jinshan, Wang Maoqiang, Li Huai. Advances in the application of interventional therapy for benign prostatic hyperplasia. Chinese Journal of Radiology, 2006，40（8）：876-878.

Professor Zhang Jinshan is the corresponding author. This paper systematically reviews the cutting-edge advances in interventional therapy for benign prostatic hyperplasia, including the principles, procedures, and efficacy of techniques such as prostatic artery embolization and stent placement, providing new insights for the minimally invasive treatment of benign prostatic hyperplasia.

8.Zhang Jinshan, Li Huai, Wang Maoqiang. Discussion on the standardization of interventional therapy for liver cancer. Chinese Journal of Practical Surgery, 2008，28（10）：856-858.

Professor Zhang Jinshan is the corresponding author. Drawing on years of clinical experience and research findings, he led the discussion on standardized protocols for interventional therapy of liver cancer, covering key aspects such as preoperative assessment, treatment modality selection, and postoperative management, providing important references for the formulation of clinical guidelines for interventional therapy of liver cancer in China.

Professor Zhang Jinshan co-authored monographs

1. Interventional Radiology (People's Military Medical Press, 1995): The first monograph in China to systematically discuss the theories and techniques of interventional radiology. It comprehensively elaborates on the interventional diagnosis and treatment system for tumors, vascular diseases, and non-vascular diseases, becoming a classic essential textbook for interventional physicians in China.

2.Interventional Therapy for Liver Cancer (People's Health Press, 2001): Focusing on minimally invasive interventions for liver cancer, this book systematically summarizes techniques such as TACE, ablation, and vascular intervention, refines operational standards and the prevention and management of complications, and promotes the standardization of interventional therapy for liver cancer.

3.Interventional Treatment of Portal Hypertension (Science Press, 2005): This book systematically elaborates on minimally invasive techniques for portal hypertension, such as TIPSS and B-ORTO, covering experimental research, clinical procedures, long-term follow-up, and efficacy evaluation, filling the gap in monographs on interventional treatment of portal hypertension in China.

Professor Zhang Jinshan’s Research project

1.The National "Eighth Five-Year Plan" Scientific and Technological Key Project—Clinical and Basic Research on Comprehensive Interventional Therapy for Liver Cancer (Project Leader): This project systematically explored multimodal interventional strategies for liver cancer, established the core regimen of superselective TACE combined with local ablation, and significantly improved the therapeutic outcomes for intermediate and advanced liver cancer.

2.The Military "Ninth Five-Year Plan" Key Medical Scientific Research Project—Standardized Research on TIPSS for the Treatment of Portal Hypertension (Project Leader): This project formulated China's first operational standards and postoperative management guidelines for TIPSS, reduced the incidence of complications, and promoted the popularization of this technique throughout the military and across the country.

3.National Natural Science Foundation of China Project — Research on the Mechanism of Targeted Therapy for Liver Cancer Using Hepatic Vein Occlusion Combined with Chemoembolization (Project Leader): This project revealed the synergistic enhancement mechanisms of the innovative technique at the levels of hemodynamics, drug metabolism, and the tumor microenvironment, providing theoretical support for precision interventional therapy of liver cancer.

4.Military Clinical High-Tech Major Project-Establishment and Clinical Application of the Interventional Treatment Technology System for Complex Vascular Diseases (Project Leader): This project overcame interventional challenges in complex lesions such as Budd-Chiari syndrome, peripheral vascular occlusion, and vascular malformations, forming a complete technical system that has been promoted and applied widely.